Stocks
GlaxoSmithKline (GSK) P/FCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 13.7 | 13.7 | 27.5 | 38.1 | 38.0 | 20.3 | |||
| Changes by years, y/y, % | -2% | 0% | +100% | +38% | 0% | +27.4% | |||
GlaxoSmithKline. P/FCF
GlaxoSmithKline. P/FCF, changes, %
GlaxoSmithKline (GSK) P/FCF US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| P/FCF | 17.3 | 15.5 | 33.3 | 17.7 | 19.3 | 20.3 | ||
| Changes by years, y/y, % | -67% | -75% | -47% | -24% | -17% | |||
| Changes by quarters, q/q, % | -52% | -10% | +114% | -47% | +9% | |||
